Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Jean Richard Eveillard"'
Autor:
Enrique M. Ocio, Yvonne A. Efebera, Roman Hájek, Jan Straub, Vladimir Maisnar, Jean-Richard Eveillard, Lionel Karlin, María-Victoria Mateos, Albert Oriol, Vincent Ribrag, Paul G. Richardson, Stefan Norin, Jakob Obermüller, Nicolaas A. Bakker, Luděk Pour
Publikováno v:
Haematologica, Vol 109, Iss 3 (2023)
Melphalan flufenamide (melflufen), a first-in-class, alkylating peptide-drug conjugate, demonstrated clinical benefit in combination with dexamethasone in triple-class refractory multiple myeloma (MM). The phase I/IIa ANCHOR study evaluated melflufen
Externí odkaz:
https://doaj.org/article/2fc23bce08c444d98389254c7b7873ab
Autor:
Enrique Maria Ocio San Miguel, Yvonne A. Efebera, Roman Hájek, Jan Straub, Vladimir Maisnar, Jean-Richard Eveillard, Lionel Karlin, Maria-Victoria Mateos, Albert Oriol, Vincent Ribrag, Paul Richardson, Stefan Norin, Jakob Obermüller, Nicolaas A. Bakker, Ludek Pour
Publikováno v:
HemaSphere, Vol 7, p e2842627 (2023)
Externí odkaz:
https://doaj.org/article/e8b2fb37406c41c09b0b8b4194d694ec
Autor:
Anais Schavgoulidze, Valerie Lauwers-Cances, Aurore Perrot, Titouan Cazaubiel, Marie-Lorraine Chretien, Philippe Moreau, Thierry Facon, Xavier Leleu, Lionel Karlin, Anne-Marie Stoppa, Olivier Decaux, Karim Belhadj, Bertrand Arnulf, Mohamad Mohty, Clara M ariette, Cecile Fohrer-Sonntag, Pascal Lenain, Jean-Pierre Marolleau, Mourad Tiab, Carla Araujo, Frederique Orsini-Piocelle, Arnaud Jaccard, Murielle Roussel, Lotfi Benboubker, Jean-Richard Eveillard, Mamoun Dib, Marion Divoux, Michel Attal, Herve Avet-Loiseau, Jill Corre
Publikováno v:
Haematologica, Vol 108, Iss 5 (2022)
In the era of personalized treatment in multiple myeloma, high-risk patients must be accurately identified. The International Myeloma Working Group recommends using the Revised International Staging System (R-ISS) to pick out high-risk patients. The
Externí odkaz:
https://doaj.org/article/044ad7cfe7874b16a7604bbd4a782f5e
Autor:
Christophe Nicol, Leela Raj, Gaëlle Guillerm, Francis Couturaud, Jean‐Richard Eveillard, Brigitte Pan‐Petesch
Publikováno v:
Clinical Case Reports, Vol 8, Iss 5, Pp 900-904 (2020)
Abstract Acquired von Willebrand syndrome is a rare bleeding disorder often secondary to an underlying lymphoproliferative disorder. We report a case in whom response of both the acquired von Willebrand syndrome and smoldering multiple myeloma persis
Externí odkaz:
https://doaj.org/article/9fc6eb4b33744ed3b66a9cf878ebd129
Autor:
Marie Orliaguet, Sylvie Boisramé, Jean‐Richard Eveillard, Brigitte Pan‐Petesch, Marie‐Anne Couturier, Vincent Rebière, Gaelle Guillerm, Marie‐Caroline Le Bousse‐Kerdiles, Laurent Misery, Eric Lippert, Jean‐Christophe Ianotto
Publikováno v:
eJHaem, Vol 1, Iss 1, Pp 350-352 (2020)
Externí odkaz:
https://doaj.org/article/d689e41da825424e99c44834057adbdc
Autor:
Murielle Roussel, Valérie Lauwers-Cances, Margaret Macro, Xavier Leleu, Bruno Royer, Cyrille Hulin, Lionel Karlin, Aurore Perrot, Cyrille Touzeau, Marie-Lorraine Chrétien, Sophie Rigaudeau, Mamoun Dib, Emmanuelle Nicolas-Virelizier, Martine Escoffre-Barbe, Karim Belhadj, Clara Mariette, Anne-Marie Stoppa, Carla Araujo, Chantal Doyen, Jean Fontan, Brigitte Kolb, Laurent Garderet, Sabine Brechignac, Jean-Valère Malfuson, Arnaud Jaccard, Pascal Lenain, Cécile Borel, Benjamin Hebraud, Omar Benbrahim, Véronique Dorvaux, Salomon Manier, Karine Augeul-Meunier, Marie-Christiane Vekemans, Edouard Randriamalala, Driss Chaoui, Jo Caers, Carine Chaleteix, Lofti Benboubker, Laure Vincent, Sylvie Glaisner, Patricia Zunic, Borhane Slama, Jean-Richard Eveillard, Catherine Humbrecht-Kraut, Véronique Morel, Philippe Mineur, Jean-Claude Eisenmann, Hélène Demarquette, Valentine Richez, Marguerite Vignon, Denis Caillot, Thierry Facon, Philippe Moreau, Anne-Laurène Colin, Pascale Olivier, Soraya Wuilleme, Hervé Avet-Loiseau, Jill Corre, Michel Attal
Publikováno v:
Blood, Vol. 139, no. 18, p. 2747-2757 (2022)
High-dose melphalan (HDM) and transplantation are recommended for eligible patients with multiple myeloma. No other conditioning regimen has proven to be more effective and/or safer. We previously reported in a phase 2 study that bortezomib can safel
Autor:
Yan Jiang, Jean-Richard Eveillard, Marie-Anne Couturier, Benoit Soubise, Jian-Min Chen, Sujun Gao, Audrey Basinko, Frédéric Morel, Nathalie Douet-Guilbert, Marie-Bérengère Troadec
Publikováno v:
Cancers, Vol 13, Iss 3, p 481 (2021)
This study explores the hypothesis that genetic differences related to an ethnic factor may underlie differences in phenotypic expression of myelodysplastic syndrome (MDS). First, to identify clear ethnic differences, we systematically compared the e
Externí odkaz:
https://doaj.org/article/4bcb066614b945f38f6abde08a9b9dc0
Autor:
Ronan Le Calloch, Karine Lacut, Christelle Le Gall-Ianotto, Emmanuel Nowak, Morgane Abiven, Adrian Tempescul, Florence Dalbies, Jean-Richard Eveillard, Valérie Ugo, Stéphane Giraudier, Gaëlle Guillerm, Eric Lippert, Christian Berthou, Jean-Christophe Ianotto
Publikováno v:
Haematologica, Vol 103, Iss 4 (2018)
The purpose of this study was to identify the incidence, causes and impact of non-adherence to oral and subcutaneous chronic treatments for patients with polycythemia vera or essential thrombocythemia. Patients receiving cytoreductive drugs for polyc
Externí odkaz:
https://doaj.org/article/e8f8e7f68f9a4858b85dddfdc69dc78d
Autor:
Vincent Rebière, Meriem Maajem, Ronan Le Calloch, Leela Raj, Anne-Sophie Le Bris, Mohamed Malou, François Salmon, Isabelle Quintin-Roué, Adrian Tempescul, David Bourhis, Laura Samaison, Hussam Saad, Pierre-Yves Salaun, Christian Berthou, Jean-Christophe Ianotto, Ronan Abgral, Jean-Richard Eveillard
Publikováno v:
Frontiers in Nuclear Medicine. 2
Currently, prognostic models in diffuse large B-cell lymphoma (DLBCL) fail to closely reflect patients' biological, clinical, and survival heterogeneity. We, therefore, assessed the impact of clinical, biological, immunohistochemical (IHC), baseline
Autor:
Leela Raj, Gaelle Guillerm, Brigitte Pan-Petesch, Jean-Richard Eveillard, Christophe Nicol, Francis Couturaud
Publikováno v:
Clinical Case Reports
Clinical Case Reports, Vol 8, Iss 5, Pp 900-904 (2020)
Clinical Case Reports, Vol 8, Iss 5, Pp 900-904 (2020)
Acquired von Willebrand syndrome is a rare bleeding disorder often secondary to an underlying lymphoproliferative disorder. We report a case in whom response of both the acquired von Willebrand syndrome and smoldering multiple myeloma persist 14 mont